Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The role of extracellular vesicle fusion with target cells in triggering systemic inflammation

P. Papareddy, I. Tapken, K. Kroh, RK. Varma Bhongir, M. Rahman, M. Baumgarten, EI. Cim, L. Györffy, E. Smeds, A. Neumann, S. Veerla, J. Olinder, H. Thorlacus, C. Ryden, E. Bartakova, M. Holub, H. Herwald

. 2024 ; 15 (1) : 1150. [pub] 20240207

Language English Country England, Great Britain

Document type Journal Article

Grant support
20180506 and 202110908 Crafoordska Stiftelsen (Crafoord Foundation)
2019-01086 Vetenskapsrådet (Swedish Research Council)

Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007182
003      
CZ-PrNML
005      
20240423155757.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-024-45125-1 $2 doi
035    __
$a (PubMed)38326335
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Papareddy, Praveen $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden. praveen.papareddy@med.lu.se $1 https://orcid.org/000000023872478X
245    14
$a The role of extracellular vesicle fusion with target cells in triggering systemic inflammation / $c P. Papareddy, I. Tapken, K. Kroh, RK. Varma Bhongir, M. Rahman, M. Baumgarten, EI. Cim, L. Györffy, E. Smeds, A. Neumann, S. Veerla, J. Olinder, H. Thorlacus, C. Ryden, E. Bartakova, M. Holub, H. Herwald
520    9_
$a Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a NF-kappa B $x metabolismus $7 D016328
650    12
$a extracelulární vezikuly $x metabolismus $7 D000067128
650    _2
$a biologický transport $7 D001692
650    _2
$a signální transdukce $7 D015398
650    _2
$a zánět $x patologie $7 D007249
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tapken, Ines $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden $u SMATHERIA gGmbH - Non-Profit Biomedical Research Institute, Hannover, Germany $u Center for Systems Neuroscience (ZSN), Hannover, Germany $1 https://orcid.org/0000000223580031
700    1_
$a Kroh, Keshia $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden $u Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands $1 https://orcid.org/0000000291660711
700    1_
$a Varma Bhongir, Ravi Kiran $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden $1 https://orcid.org/0000000166481781
700    1_
$a Rahman, Milladur $u Section of Surgery, Department of Clinical Sciences, Lund University, Malmö, Sweden $1 https://orcid.org/0000000288834848
700    1_
$a Baumgarten, Maria $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden
700    1_
$a Cim, Eda Irem $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden
700    1_
$a Györffy, Lilla $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden
700    1_
$a Smeds, Emanuel $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden $1 https://orcid.org/000000029689826X
700    1_
$a Neumann, Ariane $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden $1 https://orcid.org/000000028636730X
700    1_
$a Veerla, Srinivas $u Division of Oncology and Pathology, Lund, Department of Clinical Sciences, Lund University, Lund, Sweden $1 https://orcid.org/0000000173286239
700    1_
$a Olinder, Jon $u Division of Infection Medicine, Helsingborg Hospital and Department of Clinical Sciences Helsingborg, Lund University, Lund, Sweden
700    1_
$a Thorlacus, Henrik $u Section of Surgery, Department of Clinical Sciences, Lund University, Malmö, Sweden
700    1_
$a Ryden, Cecilia $u Division of Infection Medicine, Helsingborg Hospital and Department of Clinical Sciences Helsingborg, Lund University, Lund, Sweden
700    1_
$a Bartakova, Eva $u Department of Infectious Diseases, First Faculty of Medicine, Charles University and Military University Hospital Prague, Praha, Czech Republic
700    1_
$a Holub, Michal $u Department of Infectious Diseases, First Faculty of Medicine, Charles University and Military University Hospital Prague, Praha, Czech Republic $1 https://orcid.org/0000000318942605 $7 xx0018615
700    1_
$a Herwald, Heiko $u Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden. heiko.hewald@med.lu.se $1 https://orcid.org/0000000281112842 $7 nlk20050163289
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 15, č. 1 (2024), s. 1150
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38326335 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155753 $b ABA008
999    __
$a ok $b bmc $g 2081271 $s 1216949
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c 1 $d 1150 $e 20240207 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
GRA    __
$a 20180506 and 202110908 $p Crafoordska Stiftelsen (Crafoord Foundation)
GRA    __
$a 2019-01086 $p Vetenskapsrådet (Swedish Research Council)
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...